meningococcal ACYW135 + haemophilus influenzae b vaccine (Beijing Zhifei Luzhu Biopharmaceutical)

N/A

Report date: 2025/12/12 17:32:17

Base Information

Drug Namemeningococcal ACYW135 + haemophilus influenzae b vaccine (Beijing Zhifei Luzhu Biopharmaceutical)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHaemophilus InfectionsMeningitis, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Zhifei Lvzhu Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHaemophilus InfectionsMeningitis, Bacterial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A